GeneDx Holdings Corp. (WGS)
66.46
-1.00
(-1.48%)
USD |
NASDAQ |
Apr 16, 13:48
GeneDx Holdings Research and Development Expense (Annual) : 70.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Illumina, Inc. | 951.00M |
| Natera, Inc. | 624.11M |
| Guardant Health, Inc. | 364.19M |
| Delcath Systems, Inc. | 29.25M |
| CytoSorbents Corp. | 5.085M |